OVERVIEW

The Vascular Patches Market is expected to reach USD 652.6 million by 2026, growing at a CAGR of 8.5% during the forecast period. The growth of the vascular patches market is due to the benefits linked with stenosis or occlusion of blood vessels. Presently, the autologous vessels, like the saphenous vein and internal thoracic artery, are the gold standard for several vascular surgeries. A detailed report on the impact of COVID-19 on the Vascular Patches Market is included in the report for 2021 and beyond.

TABLE OF CONTENT

1 Global Vascular Patches Market

• 1.1 Study Objectives
• 1.2 Market Definition
• 1.3 Study Scope
  • 1.3.1 Markets Covered
  • 1.3.2 Geographic Scope

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Vascular Patches Market – Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Vascular Patches Market – Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Vascular Patches Market – Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis – Top 10 companies

• 6 Global Vascular Patches Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Vascular Patches Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Vascular Patches Market – By Material (Market Size – & million/billion)
  • 8.1 Biologic Vascular Patches
  • 8.2 Synthetic Vascular Patches

• 9 Global Vascular Patches Market - By Application
  • 9.1 Carotid Endarterectomy
  • 9.2 Open Repair of Abdominal Aortic Aneurysms
  • 9.3 Vascular Bypass Surgery
  • 9.4 Other

• 10 Global Vascular Patches Market - By End-User
  • 10.1 Hospitals & Clinics
  • 10.2 Ambulatory Surgical Centers

• 11 Global Vascular Patches Market – By Geography (Market Size – & million/billion)
  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 U.K
    • 11.3.2 Germany
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Rest of APAC
  • 11.5 Rest of the World
    • 11.5.1 South America
    • 11.5.2 Middle East
    • 11.5.3 Africa

• 12 Global Vascular Patches Market – Entropy
  • 12.1 New product launches
  • 12.2 M&A's, collaborations, JVs and partnerships

• 13 Global Vascular Patches Market Company Profile (Key Players)
  • 13.1 Market Share, Company Revenue, Products, M&A, Developments
  • 13.2 Lemaitre Vascular
  • 13.3 Baxter International
  • 13.4 Maquet (Subsidiary of Getinge Ab)
  • 13.5 B.Braun
  • 13.6 Edwards Lifesciences
  • 13.7 Labcor
  • 13.8 Terumo Corporation
  • 13.9 W. L. Gore & Associates
  • 13.10 Cryolife
  • 13.11 C. R. Bard
  • 13.12 Company 11 & more

• 14 Global Vascular Patches Market - Appendix
  • 14.1 Sources
  • 14.2 Abbreviations